A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.
From the overall spotted trades, 15 are puts, for a total amount of $1,630,528 and 3, calls, for a total amount of $148,050.
What's The Price Target?
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $160.0 to $400.0 for Moderna over the last 3 months.
Volume & Open Interest Development
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Moderna's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale trades within a strike price range from $160.0 to $400.0 in the last 30 days.
Moderna Option Volume And Open Interest Over Last 30 Days
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | SWEEP | BULLISH | 01/20/23 | $220.00 | $444.2K | 2.5K | 1 |
| MRNA | PUT | SWEEP | BULLISH | 01/21/22 | $170.00 | $275.8K | 3.3K | 1.1K |
| MRNA | PUT | TRADE | NEUTRAL | 02/18/22 | $360.00 | $180.0K | 175 | 12 |
| MRNA | PUT | TRADE | BULLISH | 01/20/23 | $220.00 | $160.5K | 2.5K | 139 |
| MRNA | PUT | SWEEP | BEARISH | 01/21/22 | $270.00 | $113.8K | 2.5K | 0 |
Where Is Moderna Standing Right Now?
- With a volume of 4,116,235, the price of MRNA is down -2.41% at $163.49.
- RSI indicators hint that the underlying stock may be oversold.
- Next earnings are expected to be released in 34 days.
What The Experts Say On Moderna:
- B of A Securities upgraded its action to Neutral with a price target of $180
- UBS downgraded its action to Neutral with a price target of $221
- Morgan Stanley has decided to maintain their Equal-Weight rating on Moderna, which currently sits at a price target of $315.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you are already an options trader or would like to get started, head on over to Benzinga Pro. Benzinga Pro gives you up-to-date news and analytics to empower your investing and trading strategy.
